Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?

被引：0
|
作者：
Wyndaele, JJ [1 ]
机构：
[1] Univ Antwerp, Dept Urol, Edegem, Belgium
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2006年 / 3卷 / 04期
关键词：
antimuscarinic; overactive bladder syndrome; solifenacin succinate; tolterodine;
D O I：
10.1038/ncpuro0440
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [41] Toprol-XL - Metoprolol succinate extended-release tablets - Astrazeneca - Once-daily treatment of heart failure
    不详
    [J]. FORMULARY, 2001, 36 (04) : 254 - 255
  • [42] Study of the Population Pharmacokinetic Characteristics of Once-Daily Trospium Chloride 60 mg Extended-Release Capsules in Patients with Overactive Bladder and in Healthy Subjects
    Mark D. Harnett
    James Shipley
    Laura MacLean
    Ute Schwiderski
    Bobby W. Sandage
    [J]. Clinical Drug Investigation, 2013, 33 : 133 - 141
  • [43] Study of the Population Pharmacokinetic Characteristics of Once-Daily Trospium Chloride 60 mg Extended-Release Capsules in Patients with Overactive Bladder and in Healthy Subjects
    Harnett, Mark D.
    Shipley, James
    MacLean, Laura
    Schwiderski, Ute
    Sandage, Bobby W., Jr.
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (02) : 133 - 141
  • [44] Once-daily amoxicillin immediate- and extended-release bilayer tablets
    Fu, Qiang
    Su, Xiaonan
    Hou, Yanxian
    Li, Mo
    Li, Jingru
    Sun, Jin
    He, Zhonggui
    [J]. POWDER TECHNOLOGY, 2016, 301 : 405 - 411
  • [45] Canadian economic comparison of extended-release oxybutynin and immediate-release tolterodine in the treatment of overactive bladder
    Getsios, D
    Caro, JJ
    Ishak, KJ
    El-Hadi, W
    Payne, K
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (03) : 431 - 438
  • [46] Cost-effectiveness analysis of extended-release tolterodine versus immediate-release tolterodine in the management of overactive bladder in spain
    Castro, D
    Soto, J
    Exposito, I
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 798 - 798
  • [47] A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder
    S. Swift
    A. Garely
    T. Dimpfl
    C. Payne
    [J]. International Urogynecology Journal, 2003, 14 : 50 - 55
  • [48] Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients
    Altieri, Mario
    Delaval, Guillaume
    Kimmoun, Elisabeth
    Allaire, Manon
    Salame, Ephrem
    Dumortier, Jerome
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 (03) : 321 - 325
  • [49] Solifenacin succinate for the treatment of overactive bladder
    Hoffstetter, Susan
    Leong, Fah Che
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (03) : 345 - 350
  • [50] A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder
    Swift, S
    Garely, A
    Dimpfl, T
    Payne, C
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2003, 14 (01) : 50 - 55
12345